Jump to main content
Jump to site search

Issue 11, 2018
Previous Article Next Article

Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy

Author affiliations

Abstract

In the context of prodrug nanomedicines for cancer therapy, one of the great challenges is the slow and variable release of the parent drug in tumors. Recently, many smart redox-sensitive nanocarriers have been developed to address this problem. However, due to significant tumor heterogeneity, some redox-sensitive nanomedicines still show poor selectivity in drug release. Herein, we report the design and synthesis of a ROS-triggered prodrug nanoplatform fabricated with oxidation-responsive cabazitaxel (CTX) prodrugs for synergistic chemo-photodynamic therapy, thioether-/selenoether-linked conjugates of CTX and oleic acid (OA). These prodrugs can be readily self-assembled into nanoparticles, with pyropheophorbide a (PPa) co-encapsulated into the prodrug-nanosystem for combination therapy. The dual-source ROS-responsive prodrug nanosystems selectively and rapidly release CTX not only in response to endogenous ROS overproduced in tumor cells, but also to exogenous PPa-generated ROS under laser irradiation. Moreover, the selenium-containing linkage demonstrates significant advantages over a sulfur-containing linkage in terms of ROS-triggered drug release and cytotoxicity. The prepared prodrug-nanosystems significantly prolong the systemic circulation and tumor distribution of both CTX and PPa, thereby demonstrating synergistic chemo-photodynamic therapy in vivo. All these drug delivery advantages render the nanosystem extremely promising for cancer treatment.

Graphical abstract: Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 31 Jul 2018, accepted on 07 Sep 2018 and first published on 12 Sep 2018


Article type: Paper
DOI: 10.1039/C8BM00899J
Citation: Biomater. Sci., 2018,6, 2965-2975
  •   Request permissions

    Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy

    B. Yang, K. Wang, D. Zhang, B. Sun, B. Ji, L. Wei, Z. Li, M. Wang, X. Zhang, H. Zhang, Q. Kan, C. Luo, Y. Wang, Z. He and J. Sun, Biomater. Sci., 2018, 6, 2965
    DOI: 10.1039/C8BM00899J

Search articles by author

Spotlight

Advertisements